Denali Therapeutics Inc (DNLI)
SG&A Expense Growth
18.32%
Quarterly · Period ending:
DNLI SG&A Expense Growth
Latest reported18.32%period ending
Latest reported18.32%period ending
DNLI Quarterly SG&A Growth (QoQ) (0.00% → 18.32%)
Latest values, visible window
High-resolution chart · PNG
DNLI sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 18.3167% | |
| -16.1994% | |
| 3.1282% | |
| 9.9699% | |
| 9.9274% | |
| -2.3487% | |
| 20.4818% | |
| -0.9725% | |
| -0.1664% | |
| 1.8854% | |
| -2.1955% | |
| -3.0436% | |
| -3.7583% | |
| 15.4108% | |
| 1.1049% | |
| 9.9249% | |
| -6.1311% | |
| 3.5939% | |
| 12.6301% | |
| 1.4387% | |
| 0.5756% | |
| 5.2351% | |
| 13.85% | |
| 13.1191% | |
| 11.2863% | |
| 15.4058% | |
| -2.996% | |
| -25.6102% | |
| 61.9334% | |
| -15.7085% | |
| 24.9717% | |
| 28.1613% | |
| 23.8061% | |
| 9.8836% | |
| 34.3493% | |
| 5.8642% | |
| 8.8577% | |
| 7.4852% | |
| -2.1523% | |
| 11.7373% | |
| 0% | |
| 0% |